For Richmond weight management patients , this medication works by naturally reducing appetite and increasing satiety, supporting sustainable weight loss through reduced caloric intake
doi: 10.1016/j.peptides.2024.171212 Summary Keywords GIP -glucose-dependent insulinotropic polypeptide, antagonism, obesity, diabetes, pharmacology Citation Koefoed-Hansen F, Helsted MM, Kizilkaya HS, Lund AB, Rosenkilde MM and Gasbjerg LS (2025) The evolution of the therapeutic concept GIP receptor antagonism
This made tirzepatide the first and only prescription medication approved specifically for this indication
Precursors (NAC, Whey Protein, B Vitamins) Supports natural glutathione production
Zepbound and obstructive sleep apnea In late 2024, the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity